Literature DB >> 21147104

Glaucoma patients present increased levels of diadenosine tetraphosphate, Ap(4)A, in the aqueous humour.

Marta Castany1, Isabel Jordi, Jaume Catala, Arcadi Gual, Miguel Morales, Xavier Gasull, Jesus Pintor.   

Abstract

Previous studies have shown the presence of diadenosine tetraphosphate (Ap(4)A) and pentaphosphate (Ap(5)A) in the aqueous humour (AH) of different species. When topically applied to the rabbit cornea, Ap(4)A decreased IOP while Ap(5)A increased it. Here we study the presence of dinucleoside polyphosphates in the AH from human patients with or without glaucoma. AH was obtained at the time of cataract surgery from patients with (n=16) or without (n=10) primary open-angle glaucoma. AH (0.1-0.2 ml) was collected at the beginning of surgery through a corneal paracentesis and immediately cooled in liquid nitrogen, kept frozen and protected from light. AH aliquots were analyzed by HPLC for the presence of Ap(4)A and Ap(5)A. Both, Ap(4)A and Ap(5)A were detected in the AH of both experimental groups. No significant differences were found for Ap(5)A. In contrast, Ap(4)A levels were increased by ∼15-fold in the AH from glaucomatous eyes ranging from 19.5±9.2 nM in normal individuals to 286.03±30.9 nM in glaucomatous patients. In conclusion, both Ap(4)A and Ap(5)A were detected for the first time in human AH. Interestingly, glaucomatous eyes presented elevated concentrations of Ap(4)A compared to controls. The role of Ap(4)A needs to be elucidated but it may help to protect the autonomic innervation in the ciliary body/trabecular meshwork. Also, because of its higher levels in glaucoma patients it may be considered as a possible glaucoma biomarker.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147104     DOI: 10.1016/j.exer.2010.12.004

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  14 in total

Review 1.  Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.

Authors:  Kenneth A Jacobson; Silvia Paoletta; Vsevolod Katritch; Beili Wu; Zhan-Guo Gao; Qiang Zhao; Raymond C Stevens; Evgeny Kiselev
Journal:  Mol Pharmacol       Date:  2015-04-02       Impact factor: 4.436

Review 2.  Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.

Authors:  A Guzman-Aranguez; P Loma; J Pintor
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

3.  Editorial.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2011-06       Impact factor: 3.765

4.  Silencing of P2Y(2) receptors reduces intraocular pressure in New Zealand rabbits.

Authors:  Alba Martin-Gil; María Jesús Perez de Lara; Almudena Crooke; Concepción Santano; Assumpta Peral; Jesus Pintor
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Increased Ap4A levels and ecto-nucleotidase activity in glaucomatous mice retina.

Authors:  María J Pérez de Lara; Ana Guzmán-Aranguez; Rosa Gómez-Villafuertes; Javier Gualix; María Teresa Miras-Portugal; Jesús Pintor
Journal:  Purinergic Signal       Date:  2018-06-08       Impact factor: 3.765

Review 6.  Ocular Purine Receptors as Drug Targets in the Eye.

Authors:  Kenneth A Jacobson; Mortimer M Civan
Journal:  J Ocul Pharmacol Ther       Date:  2016-08-30       Impact factor: 2.671

7.  Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma.

Authors:  Begoña Fonseca; Alejandro Martínez-Águila; María J Pérez de Lara; Jesús Pintor
Journal:  Purinergic Signal       Date:  2016-11-16       Impact factor: 3.765

8.  A survey of preoperative blood tests in primary open-angle glaucoma patients versus cataract surgery patients.

Authors:  Laura P Cohen; Jessica Wong; Aliya Z Jiwani; Scott H Greenstein; Stacey C Brauner; Sherleen C Chen; Angela V Turalba; Teresa C Chen; Lucy Shen; Douglas J Rhee; Janey L Wiggs; Jae Hee Kang; Stephanie Loomis; Louis R Pasquale
Journal:  Digit J Ophthalmol       Date:  2014-06-30

9.  Purinergic dysregulation causes hypertensive glaucoma-like optic neuropathy.

Authors:  Youichi Shinozaki; Kenji Kashiwagi; Kazuhiko Namekata; Akiko Takeda; Nobuhiko Ohno; Bernard Robaye; Takayuki Harada; Takeshi Iwata; Schuichi Koizumi
Journal:  JCI Insight       Date:  2017-10-05

10.  Increased levels of extracellular ATP in glaucomatous retinas: Possible role of the vesicular nucleotide transporter during the development of the pathology.

Authors:  María J Pérez de Lara; Ana Guzmán-Aránguez; Pedro de la Villa; Juan Ignacio Díaz-Hernández; María Teresa Miras-Portugal; Jesús Pintor
Journal:  Mol Vis       Date:  2015-09-02       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.